Sepsis & infection

Prevalent diabetes and long-term cardiovascular outcomes in adult sepsis survivors: a population-based cohort study

Crit CarePublished Population-based cohort study

Main finding · Major CVD (MI, stroke, cardiovascular death)Result — go to the resultHazard ratio 1.25 95% CI 1.22–1.29

Authors' conclusion

Sepsis survivors with pre-existing diabetes experience a higher long-term hazard of major cardiovascular events when compared to sepsis survivors without diabetes.

Study context

Population
Adult survivors of a first sepsis-associated hospitalization without pre-existing CVD, Ontario, Canada, 2008–2017matched cohort
Exposure
Pre-existing diabetes vs no pre-existing diabetes among sepsis survivors
  • Diabetesn = 78,638
Outcome
Composite of:
  • MI
  • Stroke
  • Cardiovascular death
Follow-up
Up to 5 years from discharge
Methodological detailspropensity-score matched (1:1)
  • Propensity-score matched (1:1)

Main finding

Major CVD (MI, stroke, cardiovascular death)

Hazard ratio

1.25

95% CI 1.22–1.29

Diabetes vs No diabetes
HR 1.25 (95% CI 1.22–1.29)

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeHR (95% CI)
MI1.40 (1.34–1.47)
Stroke1.24 (1.18–1.29)
OutcomeRisk difference (%) (95% CI)
Effect modification: CVD risk after sepsis vs no sepsis, by diabetes statusSepsis (with diabetes) vs No sepsis (with diabetes)2.3 (2.0–2.6)
Effect modification: CVD risk after sepsis vs no sepsis, by diabetes statusSepsis (without diabetes) vs No sepsis (without diabetes)1.8 (1.6–2.0)

Effect modification: CVD risk after sepsis vs no sepsis, by diabetes status

Pre-existing diabetes modified the association between sepsis and CVD

Original publication

Prevalent diabetes and long-term cardiovascular outcomes in adult sepsis survivors: a population-based cohort study. Crit Care. Published 31 July 2023. doi:10.1186/s13054-023-04586-4

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.